New Horizons – Symposium

Upcoming Conference
October 28, 2021 – October 29, 2021

Register now to save your spot! You will be able to access all of the Symposium sessions and the recordings afterward. Best of all, registration is complimentary. Hope you can join us!


LYNNE YAO, MD

Director at Division of Pediatric and Maternal Health at US FDA, CDER; Keynote Speaker

JEFF BARRETT, PHD

Senior Vice President at Critical Path Institute

HANNAH BATCHELOR, PHD

Professor at Strathclyde Institute of Pharmacy and Biomedical Science

ALEX BLIU, PHD

Senior Biostatistician with the Office of Biostatistics, Health Canada

AMY CHEUNG, PHD

Senior Director of Integrated Drug Development at Certara

ELIN HAF DAVIES, PHD

CEO of Aparito

LYNNE GEORGOPOULOS, RN, MSHS

VP, Regulatory Strategy at Certara

BARRY MANGUM, PHARMD

CEO, Paidion Research

LILY MULUGETA, PHARMD

Associate Director, FDA

ROBERT NELSON, MD, PHD

Senior Director, Pediatric Drug Development, Child Health Innovation Leadership Department at Johnson & Johnson

GREGORY REAMAN, MD

Associate Director for Oncology Sciences at Center for Drug Evaluation and Research, US FDA

PATRICK SMITH, PHARMD

Senior Vice President of Integrated Drug Development at Certara

MARK TURNER, PHD

Professor of Neonatology and Research Delivery at University of Liverpool

JOHN VAN DEN ANKER, MD, PHD

Chair of Pediatric Clinical Pharmacology at Children’s National Medical Center

KAREN ROWLAND YEO, PHD

Senior Vice President of Client and Regulatory Strategy at Certara

SOLANGE CORRIOL-ROHOU, MD

Sr. Director of Regulatory Affairs & Policy for Europe, AstraZeneca

JING LIU, PHD

Sr. Director of Clinical Pharmacology at Pfizer

MARK SHAPIRO, MBA, MA

Vice President Clinical Development at xCures

THERESA SHALABY, MSN, RN

Senior Regulatory Services Manager at Certara

Back to top